Skip to main navigation Skip to search Skip to main content

Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Pre-Planned Interim Analysis

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - Aug 6 2022

Cite this